Articles tagged with Breast Cancer
A new study found that hypofractionation does not increase complications for patients with breast cancer who undergo mastectomy and plan breast reconstruction. The trial enrolled 898 patients and showed that reducing treatment time by nearly half is safe and effective, saving patients time and money.
A new study finds that estrogens decrease the ability of immune cells to attack tumors and reduce the effectiveness of immunotherapies, including in triple-negative breast cancers. Anti-estrogen drugs have been shown to reverse these effects, restoring potency to immunotherapies and slowing tumor growth.
Researchers propose a two-pronged attack on the enzyme glutaminase and protein HuR to combat breast cancer. Simultaneous inhibition of both is shown to significantly reduce breast cancer cell growth and invasion by increasing dependence on glutamine.
Early-stage HR+ breast cancer survivors experience weight gain, particularly those with healthy BMI or overweight at diagnosis. Black women have higher rates of obesity and related comorbidities compared to White women, leading to a 40% higher breast cancer mortality rate.
A new online tool has been shown to reduce decisional conflict in women with breast cancer undergoing mastectomy, supporting informed decisions on immediate breast reconstruction. The study found that patients who used the tool felt better prepared for decision-making and had a lower rate of clinically significant decisional conflict.
According to the Global Cancer Observatory (GLOBOCAN), lung cancer is the most common type of cancer, with 2.2 million new cases and 1.8 million deaths worldwide in 2020. China had the highest number of new cases, and incidence and mortality rates have been steadily rising from 1990 to 2019.
Researchers have developed an AI technology that can analyze mammary tissue biopsies to identify signs of damaged cells, a key indicator of breast cancer risk. The study found the AI was far better at predicting risk than current clinical benchmarks, offering improved treatment options for women.
Researchers have identified nearly 200 potential breast carcinogens in food contact materials, including plastics and paper, highlighting widespread exposure despite existing regulation. The findings emphasize the need for stronger preventative measures to reduce these chemicals in everyday products.
A randomized clinical trial found that a voice-activated cognitive behavioral therapy program improved insomnia symptoms in breast cancer survivors. The intervention, delivered in an in-home setting, demonstrated efficacy in reducing sleep disturbances and enhancing overall quality of life.
A recent study found that Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates than white patients. However, when they did receive immunotherapy, their overall survival rate was similar to that of white patients. The study suggests that socioeconomic factors may be the main barrie...
A study found that Black women with breast cancer are more likely to experience vaginal dryness, reduced libido, and painful intercourse, leading to lower mental quality of life. These symptoms were associated with decreased adherence to treatment in these patients.
Researchers confirm that fibrosis in HER2-negative breast tumors is associated with an adverse prognosis and better treatment outcomes with nintedanib. A new test, MeCo Score, analyzes gene activity related to fibrosis and indicates the effectiveness of supplementing chemotherapy with antifibrotic therapy.
Researchers identified over 3,000 harmful genetic changes in the RAD51C gene that increase ovarian cancer risk six-fold and breast cancer risk four-fold. These findings can help doctors and diagnostic laboratory scientists better assess cancer risk and provide more personalized care.
A 10-year study found that digital breast tomosynthesis increases cancer detection rates and reduces advanced cancers compared to conventional 2D digital mammography. DBT detected more aggressive cancers at an earlier stage than digital mammography, leading to improved cancer detection and lower recall rates.
A meta-analysis by Mass General Brigham researchers found that Black women face higher mortality rates from breast cancer across all tumor subtypes, attributed to socioeconomic inequality, delayed diagnosis, and inadequate access to timely quality treatment. This disparity is not limited to hormone-positive tumors, with differences als...
New study finds that extended estrogen suppression using aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe and does not increase the risk of coronary artery calcification. The duration of treatment and presence of osteoporosis were not associated with increased coronary artery calcification scores.
A new study from NRG Oncology found that whole-breast irradiation (WBI) was not statistically equivalent to accelerated partial-breast irradiation (APBI) in local tumor control. The QOL sub-study also showed that APBI may be preferred by some patients due to reduced fatigue and extended treatment time.
Two studies found breastfeeding after breast cancer diagnosis is safe and feasible for young patients with specific genetic variations, as well as hormone receptor-positive breast cancer survivors. A third study shows a telephone-based coaching program can significantly increase physical activity in overweight patients, potentially imp...
A drug that delivers chemotherapy directly to tumors has shown substantial and durable activity in treating brain metastases of HER2-positive breast cancer. The treatment, trastuzumab deruxtecan, has improved progression-free survival and objective response rates in patients with advanced disease.
Researchers at NYU Abu Dhabi have developed nanoscale covalent organic frameworks (nCOFs) modified with peptides to treat triple-negative breast cancer. The COFs selectively release drug cargo within the acidic environment of tumors, improving treatment effectiveness and minimizing side effects.
The study examines breast cancer incidence, mortality, and disease burden in China to inform urgent prevention and treatment strategies. The Age-Standardized Incidence Rate is relatively low compared to other countries, but the sheer number of cases and DALYs highlights a significant public health challenge.
Scientists identified two distinct patterns of B cell abnormalities, TiBA-0, TiBA-1, and TiBA-2, which are linked to an immunosuppressive effect and poorer treatment response. These biomarkers can be detected through a simple blood draw, enabling potential stratification of patients and personalized treatment.
Researchers at NTU Singapore and Oxford have identified a new process called nucleophagy that helps cells remove harmful DNA-protein lesions, promoting genetic material stability and cell survival. This discovery may improve cancer treatment outcomes for patients with colorectal cancer.
Researchers at MUSC Hollings Cancer Center discover targeting an immunosuppressive protein on two fronts reduces metastasis and restores sensitivity to immunotherapy in a preclinical model. TNBC cells become resistant to immunotherapy due to membrane instability, enabling PD-L1 protein to drop inside the cell.
Researchers identified PRMT5 as a therapeutic vulnerability for overcoming paclitaxel resistance in triple-negative breast cancer. PRMT5 inhibitors disrupt RNA splicing and chromosomal stability, inducing cell apoptosis and triggering cancer death.
A common skin fungus, Malassezia globosa, may invade deep tissues and cause tumor growth in breast cancer, according to a new study published in mBio. The researchers found that M. globosa colonizes in breast fat pads leading to tumor growth, suggesting a potential link between fungal colonization and cancer progression.
Researchers at Huntsman Cancer Institute have developed a mechanism that accurately forecasts the aggressiveness of triple-negative breast cancer (TNBC). This advancement could allow doctors to identify higher-risk patients and tailor precise treatments.
A new study reveals that the menstrual cycle plays a role in spreading mutant cells within mammary tissue, leading to large fields prone to tumor formation. Researchers observed that the growth and removal of extra milk ducts during the menstrual cycle can contribute to this process.
Researchers found a subset of macrophage cells close to breast cancer cells, which may provide a new biological target for immunotherapies. This discovery could lead to the development of biologic therapies to change the organization of neighborhoods around cancer cells.
A new study by UC Davis found that false-positive results can lead to women avoiding future screening, with Asian and Hispanic/Latinx women being the least likely to return. The research highlights the importance of continued screening for these groups despite a history of benign breast disease.
A large cohort study found that false-positive mammography results lead to a significant decrease in subsequent screening rates among women. The study, published in Annals of Internal Medicine, highlights the potential unintended consequence of false positives on routine breast cancer screening participation.
A new automated scoring system using deep learning and pyramid sampling analyzes morphological features at various spatial scales to enhance the accuracy of HER2 assessment. The system achieved a classification accuracy of 84.70% in blind testing, comparable to experienced pathologists.
Residing in persistently impoverished neighborhoods is associated with poor breast cancer outcomes, including increased mortality. The study found that women from low-income areas had poorer tumor characteristics compared to those from higher-income areas.
Researchers have developed a nanodrug that targets miR-10b, a small noncoding RNA implicated in cancer cell invasion and proliferation. The study shows that inhibiting miR-10b reduces the stemness of breast cancer cells, supporting dedifferentiation as a potential therapeutic mechanism.
Researchers at Cold Spring Harbor Laboratory have discovered a strategy to kill breast cancer cells and shrink tumors by depriving them of two vital nutrients: glutamine and its backup supply, alpha-ketoglutarate. This approach was successful in lab experiments and effective in treating tumors in mice.
Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.
Researchers have discovered that sodium chloride can increase the efficiency of antitumoral T cells, leading to improved metabolic fitness and enhanced tumor killing capabilities. This finding has significant implications for adoptive T-cell therapy in cancer treatment.
Women with regular annual mammograms had higher overall survival and lower late-stage cancer rates than those screened less frequently. The study's findings contradict current guidelines, suggesting a significant benefit to annual screening for women over 40.
Researchers found that CHEK2 variants do not increase colorectal cancer risk compared to controls. Three low-risk missense variants were identified as potential drivers of breast cancer risk variability.
A new study reveals that cellular protein Gα13 acts as a tumour suppressor in oestrogen receptor-positive (ER+) breast cancer, potentially slowing or stopping cancer cell growth. Lower levels of Gα13 are associated with poorer patient survival outcomes.
Researchers have discovered that dialyl-sulfide and trans-chalcone can prevent breast cancer by targeting SULT1E1 and HIF1a-MMPs. These compounds neutralize oxidative stress and induce the expression of SULT1E1, leading to decreased HIF1a and MMP production.
Obesity-related cancer rates in China have risen sharply among young people, with an alarming 3.6% annual increase between 2007 and 2021. The trend is particularly pronounced among those aged 25-29, highlighting the urgent need for better public health policies to address China's growing overweight and obesity rates.
A new study by UCLA investigators found that Manuka honey contains compounds that can help reduce tumor growth in preclinical models. The research suggests that Manuka honey could potentially be developed into a natural supplement or standalone treatment for ER-positive breast cancer, which accounts for most breast cancer cases.
Researchers developed a nanobody that targets V-ATPase c subunit and inhibits tumor cell invasion and metastasis. The nanobody was tested on 4T1-12B mouse breast cancer cells implanted in mice, where it showed effectiveness in preventing lung metastasis.
Recent advances highlight PIK3CA mutation significance in determining targeted therapy efficacy, particularly in advanced breast cancer. Molecular signatures and genetic profiles drive personalized treatment strategies, with emerging therapies offering new hope for patients.
A Rice University-led team is developing an affordable system to improve tumor removal accuracy for breast and head and neck cancer. The AccessPath system enables rapid, automatic tumor margin classification, revolutionizing real-time surgical guidance.
A clinical trial in Denmark found that offering women further screening opportunities during breast cancer screenings significantly increased their participation and enabled early diagnosis of other cancers. The study used a cluster-randomized crossover design and involved over 27,000 participants.
A new study provides a detailed map of healthy breast cells, shedding light on how breast cancer develops and the genetic ancestry-dependent variability in breast tissue. The research aims to identify new treatment targets and improve understanding of breast cancer development.
A trial at UT Health San Antonio found that Sacituzumab Govitecan was well-tolerated and showed signs of effectiveness for patients with breast cancer who had progressed to brain tumors. The drug has been shown to deliver a topoisomerase inhibitor into tumors, providing promising clinical signals of efficacy.
A 30-year study suggests that radiotherapy can prevent breast cancer recurrence in the same location for up to 10 years after surgery, but survival rates remain similar. The study found fewer deaths from breast cancer among those who received radiotherapy compared to those who did not.
Researchers found that sensory neurons secrete a neuropeptide driving cancer growth and spread through a previously unknown neuro-cancer crosstalk. An FDA-approved drug may prevent metastasis in breast cancer instances. The study suggests targeting this pathway to stop breast cancer progression.
A large Danish study published in Diabetologia found no association between gestational diabetes and an increased risk of breast cancer. The study included over 708,000 women and followed them for a median of 11.9 years to examine the link between the two conditions.
A recent study published in The Journal of Clinical Endocrinology and Metabolism found that women who underwent menopause before age 46 were nearly twice as likely to develop breast cancer as other women of similar ages. Relatives of these women were also more likely to have breast, prostate, or colon cancer.
A new AI protocol called DeepHRD enables accurate, instantaneous detection of cancer genomic biomarkers directly from tumor biopsy slides. This breakthrough technology saves weeks and thousands of dollars from clinical oncology treatment workflows, providing access and equity in cancer care for resource-constrained settings.
A new study uses artificial intelligence to predict which breast cancer patients are most at risk for developing chronic pain, with anxiety and depression being leading factors. The AI model was built with detailed data on over 1,000 breast cancer patients and correctly predicted chronic pain more than 80% of the time.
Researchers found that abnormal results from routine blood tests were linked to a higher risk of being diagnosed with cancer within a year. The study estimated that taking these results into account could lead to an extra six people with undiagnosed cancer being urgently referred for treatment.
A new study finds that combining an inhibitor of a metabolic pathway with chemotherapy could improve treatment outcomes in triple negative breast cancer brain metastases. Inhibiting fatty acid synthase, an enzyme critical for cancer cell survival, shows promise in improving chemotherapy efficacy.
Women with bilateral mastectomy have a greatly diminished risk of contralateral breast cancer, yet experience similar mortality rates as patients treated with lumpectomy or unilateral mastectomy. The study highlights the importance of considering long-term risks and benefits in breast cancer treatment decisions.
A randomized controlled trial found that structured exercise programs significantly improved the quality of life and reduced fatigue in women with metastatic breast cancer. The program, which included twice-weekly training sessions, also showed improvements in pain, shortness of breath, and social participation.
Researchers discovered that sodium channels allow cancer cells to grow and spread by increasing energy production and producing lactic acid, which breaks down the extracellular matrix. Blocking these channels may be an effective way to slow cancer growth and prevent metastasis in breast cancer patients.